Advancing the evidence base for child and adolescent psychopharmacology
Samuele Cortese1,2,3,4,5, Carmen Moreno6
1Developmental EPI (Evidence synthesis, Prediction, Implementation) Lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK samuele.cortese@soton.ac.uk.
Abstract:
This editorial focuses on the seven studies published in the BMJ Mental Health topic collection Advances in Clinical Psychopharmacology in Children and Young People. Collectively, these articles provide evidence that informs key steps in the psychopharmacological management of children and adolescents with mental health or neurodevelopmental conditions. Papers in this collection contribute to strengthen evidence-based psychopharmacological practice. We look forward to further developments in the field, supported by adequate research funding.
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Drug Therapy
Antianxiety Medications
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Introduction to Biological Bases of Psychology
The nervous system, the cornerstone of...
Psychosis: Goals of Pharmacotherapy
Revisionist Views of Adolescent and Adult Cognition


